74. 下垂体性PRL分泌亢進症 Disease details / Clinical trials / Drug dev / DR info


臨床試験数 : 21 / 薬物数 : 31 - (DrugBank : 11) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 65

薬物、開発者(Primary Sponsor)、臨床試験情報(症例登録開始年(Enrollment year)、フェーズ、ID、実施国)
Barley
   Huashan Hospital Affiliated to Fudan University
      2022   Phase 0   ChiCTR2200056078   China
Bromocriptin 2.5MG, 2-3 times A DAY
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2024   -   NCT06556186   -
Bromocriptine
   First affiliated hospital of Sun Yat-sen University
      2012   -   ChiCTR-ONC-12002194   -
   Huashan Hospital Affiliated to Fudan University
      2022   Phase 0   ChiCTR2200056078   China
Cabergoline
   Federico II University
      2007   -   NCT00460616   Italy
   Seoul National University Hospital
      2018   -   NCT03457389   Korea, Republic of
   Universidade Federal do Rio de Janeiro
      2010   Phase 2/Phase 3   NCT01620138   Brazil
Clomiphene citrate
   Federal University of São Paulo
      2004   Phase 2   NCT00697814   Brazil
Curcumin
   Mashhad University of Medical Sciences
      2011   Phase 1   NCT01344291   Iran, Islamic Republic of
Dexamethasone
   National Cancer Institute (NCI)
      2010   Phase 1   NCT01088763   Canada;United States
Diagnostic laboratory biomarker analysis
   National Cancer Institute (NCI)
      2010   Phase 1   NCT01088763   Canada;United States
Dopamine agonist treatment
   First Affiliated Hospital, Sun Yat-Sen University
      2016   -   NCT03353025   China
Dopamine agonists
   Leiden University Medical Center
      2019   Phase 4   NCT04107480   Netherlands
Endoscopic trans-sphenoidal adenoma resection
   Leiden University Medical Center
      2019   Phase 4   NCT04107480   Netherlands
Gamma-secretase/notch signalling pathway inhibitor RO4929097
   National Cancer Institute (NCI)
      2010   Phase 1   NCT01088763   Canada;United States
Genotropin 12MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin 5.3MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 0.2MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 0.4MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 0.6MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 0.8MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 1.0MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Genotropin miniquick 1.2MG
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
HCQ/CQ and CAB combined treatment
   Zhebao Wu
      2018   -   NCT03400865   China
Lapatinib
   Cedars-Sinai Medical Center
      2009   Phase 2   NCT00939523   United States
Pasireotide
   Memorial Sloan Kettering Cancer Center
      2024   Phase 2   NCT06295952   United States
   NOVARTIS FARMA
      2009   -   EUCTR2008-007348-32-IT   France;Germany;Italy;Spain
   Novartis Pharma Services AG
      2009   Phase 2   EUCTR2008-007348-32-FR   France;Germany;Italy;Spain
      2009   Phase 2   EUCTR2008-007348-32-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States
   Universidade Federal do Rio de Janeiro
      2010   Phase 2/Phase 3   NCT01620138   Brazil
   Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
      2008   -   EUCTR2006-007036-95-DE   Germany
Pharmacological study
   National Cancer Institute (NCI)
      2010   Phase 1   NCT01088763   Canada;United States
Ropinirole
   Columbia University
      2016   Phase 1/Phase 2   NCT03038308   United States
SF-36 and hads
   Memorial Sloan Kettering Cancer Center
      2024   Phase 2   NCT06295952   United States
SOM230
   NOVARTIS FARMA
      2009   -   EUCTR2008-007348-32-IT   France;Germany;Italy;Spain
   Novartis Pharma Services AG
      2009   Phase 2   EUCTR2008-007348-32-FR   France;Germany;Italy;Spain
      2009   Phase 2   EUCTR2008-007348-32-DE   Argentina;Australia;Brazil;Canada;Colombia;France;Germany;Italy;Mexico;Russian Federation;South Africa;Spain;United States
   Universitätsklinikum Essen - Zentrum für Innere Medizin - Klinik für Endokrinologie
      2008   -   EUCTR2006-007036-95-DE   Germany
Somatropin
   Amar Agha, Beaumont Hospital
      2009   Phase 4   EUCTR2009-010918-30-IE   Ireland
Surgery
   Zhebao Wu
      2018   -   NCT03717454   -
Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy
   Second Affiliated Hospital, School of Medicine, Zhejiang University
      2024   -   NCT06556186   -
Transsphenoidal surgery treatment
   First Affiliated Hospital, Sun Yat-Sen University
      2016   -   NCT03353025   China